Mativ (NYSE:MATV - Get Free Report) issued its earnings results on Wednesday. The company reported $0.05 EPS for the quarter, missing the consensus estimate of $0.22 by ($0.17), Zacks reports. The firm had revenue of $458.60 million during the quarter, compared to analyst estimates of $472.70 million. Mativ had a negative net margin of 2.46% and a positive return on equity of 3.86%.
Mativ Price Performance
NYSE MATV traded down $0.62 during trading on Friday, hitting $6.86. 1,689,959 shares of the company's stock were exchanged, compared to its average volume of 438,854. The company has a market cap of $372.50 million, a PE ratio of -7.62, a P/E/G ratio of 1.08 and a beta of 0.66. The company has a current ratio of 2.40, a quick ratio of 1.29 and a debt-to-equity ratio of 1.28. Mativ has a fifty-two week low of $6.25 and a fifty-two week high of $19.96. The stock's 50 day moving average price is $9.93 and its two-hundred day moving average price is $13.84.
Mativ Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 28th. Investors of record on Friday, March 14th will be paid a $0.10 dividend. This represents a $0.40 annualized dividend and a yield of 5.84%. The ex-dividend date of this dividend is Friday, March 14th. Mativ's dividend payout ratio (DPR) is presently -44.44%.
Wall Street Analyst Weigh In
Separately, Stifel Nicolaus started coverage on shares of Mativ in a research report on Thursday, November 21st. They set a "hold" rating and a $15.50 price objective for the company.
Read Our Latest Report on MATV
About Mativ
(
Get Free Report)
Mativ Holdings, Inc, together with its subsidiaries, manufactures and sells specialty materials in the United States, Europe, the Asia Pacific, the Americas, and internationally. The company operates through two segments, Advanced Technical Materials and Fiber-Based Solutions. The Advanced Technical Materials manufactures and sells various engineered polymer, resin and fiber-based substrates, nets, films, adhesive tapes, and other nonwovens for the filtration, protective solutions, release liners, and healthcare end-markets.
Further Reading
Before you consider Mativ, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mativ wasn't on the list.
While Mativ currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
